SHIRLEY TRABACHINO: Open Payments
NPI 1760573042 · PHILA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 33 payments from 10 companies in 2025. Trend: 2023 $1,966 · 2024 $1,071 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 4 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $89 |
| Amgen Inc. | 5 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| MEDICOMP INC | 4 | $77 |
| PFIZER INC. | 4 | $64 |
| Novo Nordisk Inc | 3 | $62 |
| Boston Scientific Corporation | 1 | $57 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: ONPATTRO, JARDIANCE, REPATHA, LEQVIO, TELEPATCH CARDIAC MONITOR, ELIQUIS, Wegovy, INGEVITY+.
Industry payments across PA — which companies pay providers there.
